Aphranel® Partners with MXGP Shanghai 2026
Regenerative aesthetics brand aphranel®, developed by MOYOM Biotech, served as an official partner for the 2026 MXGP Shanghai event. The brand showcased its facial contouring concept to a broad audience.
Aphranel®, a regenerative aesthetics brand developed in China by MOYOM Biotech, was an official partner of the FIM Motocross World Championship (MXGP) 2026 in Shanghai, held from September 11-13. During the event, the brand presented its concept for facial aesthetic treatments to an audience extending beyond the medical aesthetics field.
The aphranel® exhibition booth at MXGP Shanghai 2026 featured the brand's signature green color scheme combined with butterfly installations, motorcycles, and motocross exhibits. Visitors could also relax at the "aphranel Time Café." The area, themed "Own Your State. Dare to Take the Stage," attracted significant attendance and became a popular photo opportunity throughout the race weekend.
Addressing the event's predominantly male audience, aphranel® focused on male facial aesthetics. Their MagiCCrystal CaHA Biostructurer is utilized for anatomy-based facial contouring in areas such as the forehead, nose, chin, and jawline. This approach emphasizes facial proportions and structural definition while preserving the unique features of each individual.
MagiCCrystal is the result of a CaHA development program initiated by MOYOM Biotech in 2013. The product received NMPA approval as a Class III medical device in February 2025, following twelve years of research and product development. It is recognized as the first approved facial biostructurer based on calcium hydroxylapatite microspheres in China. Cumulative sales have surpassed 200,000 syringes since its market launch, and it is distributed through over 700 aesthetic medicine clinics across China. The MXGP partnership provided aphranel® with a platform to align its long-term research, technical precision, and stringent standards in biomaterials with the values esteemed in motorsports.
This collaboration is part of aphranel®'s broader efforts to introduce its China-developed regenerative aesthetics technology to an international audience. Beyond ongoing investments in biomaterial research and marketing, the brand has expanded its initiatives into sports, design, and culture. Following the Shanghai race, aphranel® continues its international expansion, guided by the philosophy of "Be With Time," connecting its scientific endeavors with evolving perspectives on contemporary aesthetics.